Early steroid withdrawal after liver transplantation for hepatocellular carcinoma

被引:21
|
作者
Zhi-Shui Chen [1 ]
Fan He [1 ]
Fan-Jun Zeng [1 ]
Ji-Pin Jiang [1 ]
Dun-Feng Du [1 ]
Bin Liu [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Inst Organ Transplanatat, Wuhan 430030, Hubei Province, Peoples R China
关键词
hepatocellular carcinoma; liver transplantation; steroids; tumor recurrence;
D O I
10.3748/wjg.v13.i39.5273
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To evaluate the impact of early steroid withdrawal on the incidence of rejection, tumor recurrence and complications after liver transplantation for advanced-stage hepatocellular carcinoma. METHODS: Fifty-four patients underwent liver transplantation for advanced-stage hepatocellular carcinoma from April 2003 to June 2005. These cases were divided into a steroid-withdrawal group (group A, n = 28) and a steroid-maintenance group (group B, n = 26). In group A, steroid was withdrawn 3 mo after transplantation. In group B, steroid was continuously used postoperatively. The incidence of rejection, 6-mo and 1-year recurrence rate of carcinoma, 1-year survival rate, mean serum tacrolimus trough level, and liver and kidney function were compared between the two groups. RESULTS: In the two groups, no statistical difference was observed in the incidence of rejection (14.3 vs 11.5%, P > 0.05), mean serum tacrolimus trough levels (6.9 +/- 1.4 vs 7.1 +/- 1.1 mu g/L, P > 0.05), liver and kidney function after 6 mo [alanine aminotransferase (ALT): 533 +/- 183 vs 617 +/- 217 nka/L, P > 0.05; creatinine: 66 +/- 18 vs 71 +/- 19 mu mol/L, P > 0.05], 6-mo recurrence rate of carcinoma (25.0 vs 42.3%, P > 0.05), and 1-year survival rate (64.2 v5 46.1%, P > 0.05). The 1-year tumor recurrence rate (39.2 vs 69.2%, P < 0.05), serum cholesterol level (3.9 +/- 1.8 vs 5.9 +/- 2.6 mmol/L, P < 0.01) and fasting blood sugar (5.1 +/- 2.1 v5 8.9 +/- 3.6 mmol/L, P < 0.01) were significantly different. These were lower in the steroid-withdrawal group than in the steroid-maintenance group. CONCLUSION: Early steroid withdrawal was safe after liver transplantation in patients with advanced-stage hepatocellular carcinoma. When steroids were withdrawn 3 mo post-operation, the incidence of rejection did not increase, and there was no demand to maintain tacrolimus at a high level. In contrast, the tumor recurrence rate and the potential of adverse effects decreased significantly. This may have led to an increase in long-term survival rate. (C) 2007 WJG. All rights reserved.
引用
收藏
页码:5273 / 5276
页数:4
相关论文
共 50 条
  • [31] Acute Hemolytic Anemia after Liver Transplantation Received Early Steroid Withdrawal in One Case.
    Chen, Yinghua
    Ju, Weiqiang
    Wang, Dongping
    He, Xiaoshun
    [J]. LIVER TRANSPLANTATION, 2014, 20 : S246 - S246
  • [32] Incidence of Rejection One Year after Liver Transplantation Associated with Early versus Late Steroid Withdrawal
    Yun, S.
    Miko, L.
    Ahmad, J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 1071 - 1071
  • [33] Effect of steroid withdrawal on late immunologic complications after liver transplantation
    Forti, D
    Rondinara, GF
    DeCarlis, L
    Sansalone, CV
    Colella, G
    Slim, OA
    DeGasperi, A
    [J]. LATE GRAFT LOSS, 1997, 28 : 196 - 196
  • [34] Comparison of steroid withdrawal after liver transplantation based on primary immunosuppression
    Smallwood, GA
    Chapman, RL
    Adams, RW
    Stieber, AC
    Boyer, TD
    Heffron, TG
    [J]. HEPATOLOGY, 1999, 30 (04) : 179A - 179A
  • [35] Early steroid withdrawal (day 6) after renal transplantation.
    Conti, DJ
    Isenberg, AL
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 166 - 166
  • [36] Tacrolimus versus cyclosporine for early steroid withdrawal after renal transplantation
    Sandrini, Silvio
    Aslam, Naveed
    Tardanico, Regina
    Setti, Gisella
    Bossini, Nicola
    Valerio, Francesca
    Insalaco, Monica
    Maffeis, Roberto
    Nodari, Franco
    Cancarini, Giovanni
    [J]. JOURNAL OF NEPHROLOGY, 2012, 25 (01) : 43 - 49
  • [37] Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma recurrence after liver transplantation
    Sun, B.
    Wen, Y.
    Han, J.
    Chen, J.
    Dong, J.
    Xia, Y.
    Shen, H.
    Hu, Z.
    [J]. TRANSPLANTATION, 2018, 102 : 277 - 277
  • [38] Successful early steroid withdrawal using a tacrolimus and mycophenolate protocol for liver transplantation
    Hassanein, T
    Freeman, J
    Oculam, CA
    Albanese, L
    Zamora, JU
    Wahlstrom, HE
    Linda, L
    [J]. HEPATOLOGY, 1996, 24 (04) : 1579 - 1579
  • [39] Adjuvant chemotherapy after liver transplantation for hepatocellular carcinoma
    Adam S Bodzin
    Richard S Finn
    Ronald W Busuttil
    [J]. Hepatobiliary & Pancreatic Diseases International, 2015, 14 (03) : 234 - 235
  • [40] Sorafenib for Recurrent Hepatocellular Carcinoma after Liver Transplantation
    Kim, Bo Hyun
    Park, Joong-Won
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2018, 33 (45)